Alpine Immune Sciences Inc (ALPN)
64.58
0.00 (0.00%)
USD |
NASDAQ |
May 03, 13:35
Alpine Immune Sciences Shareholders Equity (Quarterly): 327.94M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 327.94M |
| September 30, 2023 | 161.63M |
| June 30, 2023 | 169.39M |
| March 31, 2023 | 169.54M |
| December 31, 2022 | 179.42M |
| September 30, 2022 | 182.01M |
| June 30, 2022 | 99.54M |
| March 31, 2022 | 115.43M |
| December 31, 2021 | 120.90M |
| September 30, 2021 | 122.82M |
| June 30, 2021 | 43.83M |
| March 31, 2021 | 53.29M |
| December 31, 2020 | 62.16M |
| September 30, 2020 | 67.47M |
| June 30, 2020 | 16.23M |
| March 31, 2020 | 24.86M |
| December 31, 2019 | 29.47M |
| September 30, 2019 | 34.83M |
| June 30, 2019 | 45.42M |
| Date | Value |
|---|---|
| March 31, 2019 | 56.58M |
| December 31, 2018 | 44.59M |
| September 30, 2018 | 54.98M |
| June 30, 2018 | 66.55M |
| March 31, 2018 | 73.88M |
| December 31, 2017 | 78.92M |
| September 30, 2017 | 82.97M |
| June 30, 2017 | 46.07M |
| March 31, 2017 | 49.22M |
| December 31, 2016 | 55.44M |
| September 30, 2016 | 62.10M |
| June 30, 2016 | 68.69M |
| March 31, 2016 | 76.36M |
| December 31, 2015 | 83.49M |
| September 30, 2015 | 89.38M |
| June 30, 2015 | 95.12M |
| March 31, 2015 | -19.92M |
| December 31, 2014 | -15.75M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
16.23M
Minimum
Jun 2020
327.94M
Maximum
Dec 2023
106.64M
Average
99.54M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 17.58B |
| Eliem Therapeutics Inc | 107.60M |
| Regeneron Pharmaceuticals Inc | 25.97B |
| Vera Therapeutics Inc | 101.68M |
| Eyenovia Inc | 8.999M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 379.85M |
| Total Liabilities (Quarterly) | 51.91M |
| Current Ratio | 7.862 |
| Net Debt Paydown Yield | 0.08% |